API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2022/08/22/2502072/0/en/Resverlogix-Publishes-New-Data-Highlighting-Apabetalone-s-Benefit-in-Non-alcoholic-Fatty-Liver-Disease.html
https://www.globenewswire.com/news-release/2022/03/17/2405113/0/en/Apabetalone-s-Positive-Impact-on-Pulmonary-Arterial-Hypertension-Published-in-the-American-Journal-of-Respiratory-and-Critical-Care-Medicine.html
https://www.clinicaltrialsarena.com/news/resverlogix-apabetalones-trial-covid-19/
https://www.globenewswire.com/news-release/2022/01/18/2368307/0/en/Resverlogix-Announces-Commencement-of-Patient-Enrollment-and-Dosing-in-a-Phase-2b-Trial-for-a-Promising-Canadian-Developed-COVID-19-Treatment.html
https://www.globenewswire.com/news-release/2021/03/03/2186187/0/en/New-Published-Evidence-of-Apabetalone-s-Beneficial-Effects-on-COVID-19.html#:~:text=Publication%20Highlights%20include%3A&text=Apabetalone%20treatment%20was%20found%20to,virus'%20entry%20into%20human%20cells)
https://www.globenewswire.com/news-release/2021/01/12/2157040/0/en/Apabetalone-s-Positive-Effect-on-Hospitalized-Patients-Involving-Heart-Failure.html
https://www.globenewswire.com/news-release/2020/10/26/2114240/0/en/A-Second-Publication-Shortlists-Resverlogix-Clinical-Candidate-Apabetalone-for-its-Potential-COVID-19-Effectiveness-Including-Reducing-Cytokine-Storms.html
https://www.globenewswire.com/news-release/2020/03/30/2008314/0/en/Resverlogix-Announces-Publication-of-Key-Apabetalone-Study-BETonMACE-in-the-Journal-of-the-American-Medical-Association.html
https://finance.yahoo.com/news/resverlogix-invites-collaborations-apabetalone-trials-110010995.html